36 results on '"Papachristos, Apostolos"'
Search Results
2. Incorporating subjective survival information in mortality and change in health status predictions: A Bayesian approach
3. High response rate with extended dosing of cemiplimab in advanced cutaneous squamous cell carcinoma
4. On the Evaluation of ‘Self-perceived Age’ for Europeans and Americans
5. Lurbinectedin-induced thrombocytopenia: the role of body surface area
6. Factors incorporated into future survival estimation among Europeans
7. Subcutaneous Administration of Monoclonal Antibodies: Pharmacology, Delivery, Immunogenicity, and Learnings From Applications to Clinical Development
8. Editorial: Utilization of pharmacogenomics in clinical practice.
9. Dose Optimization in Oncology Drug Development: The Emerging Role of Pharmacogenomics, Pharmacokinetics, and Pharmacodynamics
10. Direct oral anticoagulant considerations in solid organ transplantation: A review
11. Machine learning‐guided covariate selection for time‐to‐event models developed from a small sample of real‐world patients receiving bevacizumab treatment
12. Personalizing chemotherapy dosing using pharmacological methods
13. Quantifying self-rated age
14. Safety and effectiveness of the combination acetazolamide and bicarbonates to induce alkaline diuresis in patients with rhabdomyolysis
15. Αναμενόμενη Υποκειμενική Επιβίωση και επίπεδα νοσηρότητας Ευρωπαίων ηλικίας 50 ετών και άνω. Μια μελέτη βασισμένη στα δεδομένα του SHARE
16. Accelerated Approval of Anticancer Drugs: Lessons Learned From the Example of Olaratumab
17. In Reply
18. The Urinary Microbiome and Bladder Cancer: Susceptibility and Immune Responsiveness
19. Pharmacogenomics, Pharmacokinetics and Circulating Proteins As Biomarkers for Bevacizumab Treatment Optimization in Patients with Cancer: A Review
20. Pharmacogenetics in Model-Based Optimization of Bevacizumab Therapy for Metastatic Colorectal Cancer
21. VEGF-A polymorphisms affect the pharmacologic effect of bevacizumab on VEGF-A levels in patients with metastatic colorectal cancer.
22. Correlation Between Bevacizumab Exposure and Survival in Patients with Metastatic Colorectal Cancer
23. VEGF-A and ICAM-1 Gene Polymorphisms as Predictors of Clinical Outcome to First-Line Bevacizumab-Based Treatment in Metastatic Colorectal Cancer
24. Subjective survival: An assessment of accuracy according to individual social profile
25. Subjective survival: An assessment of accuracy according to individual social profile.
26. Do we need to adopt antifungal stewardship programmes?
27. Do we need to adopt antifungal stewardship programmes?
28. Can VEGFA and ICAM1 polymorphisms predict response to bevacizumab?
29. Accelerated Approval of Anticancer Drugs: Lessons Learned From the Example of Olaratumab.
30. ON BALANCE.
31. Direct oral anticoagulant considerations in solid organ transplantation: A review
32. Drug Utilization Patterns and Costs of Erythropoiesis-Stimulating Agents in an Outpatient Setting in Greece
33. Antibody-drug conjugates: a mini-review. The synopsis of two approved medicines
34. Liposomal forms of anticancer agents beyond anthracyclines: present and future perspectives
35. Antibody-drug conjugates: a mini-review. The synopsis of two approved medicines.
36. Liposomal forms of anticancer agents beyond anthracyclines: present and future perspectives.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.